GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » Growth Rank

Bright Green (Bright Green) Growth Rank : 0 (As of Apr. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bright Green Growth Rank?

Bright Green has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Bright Green Growth Rank Related Terms

Thank you for viewing the detailed overview of Bright Green's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Green (Bright Green) Business Description

Traded in Other Exchanges
N/A
Address
1033 George Hanosh Boulevard, Grants, NM, USA, 87020
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
Executives
Gurvinder Singh officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri officer: Chief Financial Officer 450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson director, officer: Chief Executive Officer 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc. 10 percent owner 3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1